Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

被引：20

作者：

Zamagni, Elena ^{[1
]}

Nanni, Cristina ^{[2
]}

Dozza, Luca ^{[1
]}

Carlier, Thomas ^{[3
,4
]}

Tacchetti, Paola ^{[1
]}

Versari, Annibale ^{[5
]}

Chauvie, Stephane ^{[6
]}

Gallamini, Andrea ^{[7
]}

Attal, Michel ^{[8
]}

Gamberi, Barbara ^{[9
]}

Caillot, Denis ^{[10
]}

Patriarca, Francesca ^{[11
]}

Macro, Margaret ^{[12
]}

Boccadoro, Mario ^{[13
]}

Garderet, Laurent ^{[14
,15
]}

Fanti, Stefano ^{[2
]}

Perrot, Aurore ^{[16
]}

Gay, Francesca ^{[17
]}

Sonneveld, Pieter ^{[18
]}

Karlin, Lionel ^{[19
]}

Cavo, Michele ^{[1
]}

Bodet-Milin, Caroline ^{[3
,4
]}

Moreau, Philippe ^{[20
]}

Kraeber-Bodere, Francoise ^{[3
,4
]}

机构：

[1] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[2] St Orsola Malpighi Hosp, Nucl Med Unit, Bologna, Italy

[3] Nantes Univ Hosp, Nucl Med Dept, Nantes, France

[4] INSERM, CRCINA, UMR 1232, Nantes, France

[5] AO Arcispedale S Maria Nuova, SC Med Nucl Ctr PET, Reggio Emilia, Italy

[6] Santa Croce & Carle Hosp, Med Phys Unit, Cuneo, Italy

[7] Antoine Lacassagne Canc Ctr, Res Innovat & Stat, Nice, France

[8] Univ Hosp, Hematol Dept, Toulouse, France

[9] Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

[10] Univ Hosp Dijon, Dept Hematol, Dijon, France

[11] Univ Udine, Hematol & Bone Marrow Transplant Unit, Udine, Italy

[12] Caen Univ Hosp, Haematol Dept, Caen, France

[13] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Hematol Div, Turin, Italy

[14] Hop St Antoine, Paris, France

[15] Univ Hosp St Antoine, Hematol Dept, Dijon, France

[16] Univ Lorraine, Nancy, France

[17] Univ Torino, Div Hematol, Myeloma Unit, Turin, Italy

[18] Erasmus MC, Dept Hematol, Rotterdam, Netherlands

[19] Univ Claude Bernard, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France

[20] Nantes Univ Hosp, Nantes, France

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-111321

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

257

引用

页数：4

共 50 条

[21] Clinical Impact of 18f-FDG PET/CT As a Valuable Prognostic Tool for the Newly Diagnosed Multiple Myeloma with Extramedullary Disease
Baek, Dong Won
Cho, Hee Jeong
Sohn, Sang Kyun
Jung, Sung-Hoon
Moon, Hong Chae
Moon, Joon Ho
BLOOD, 2019, 134
[22] 18F-FDG kinetics in patients with multiple myeloma. Evaluation with dynamic PET-CT
Sachpekidis, C.
Strauss, L. G.
Goldschmidt, H.
Hillengass, J.
Cheng, C.
Pan, L.
Dimitrakopoulou-Strauss, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S374 - S374
[23] Prospective Evaluation of 18-F FDG PET/CT and Biopsies of Osteolytic Lesions and Random Bone Marrow Samples in Newly Diagnosed Multiple Myeloma Patients
Sauer, Sandra
Sachpekidis, Christos
Brandelik, Simone
Spira, Daniel
Huhn, Stefanie
Wagner, Barbara
Hummel, Manuela
Dimitrakopoulou-Strauss, Antonia
Mosebach, Jennifer
Delorme, Stefan
Goldschmidt, Hartmut
Mueller-Tidow, Carsten
Hillengass, Jens
BLOOD, 2018, 132
[24] The Role of 18F-FDG-PET/CT Imaging in Predicting Outcome of Patients with Newly Diagnosed Multiple Myeloma
Mena, Esther
Lindenberg, Maria Liza
Turkbey, Ismail
Adler, Stephen
Eclarinal, Philip
McKinney, Yolanda
Weaver, Juanita
Choyke, Peter
Kazandjian, Dickran
JOURNAL OF NUCLEAR MEDICINE, 2021, 62
[25] 18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
Morales-Lozano, Maria I.
Viering, Oliver
Samnick, Samuel
Rodriguez-Otero, Paula
Buck, Andreas K.
Marcos-Jubilar, Maria
Rasche, Leo
Prieto, Elena
Kortuem, K. Martin
San-Miguel, Jesus
Garcia-Velloso, Maria J.
Lapa, Constantin
CANCERS, 2020, 12 (04)
[26] Texture Analysis of 18F-FDG PET/CT Images for the Prediction of Outcome in Patients with Multiple Myeloma
Pellegrino, S.
Origlia, D.
Vallone, C.
Della Pepa, R.
Del Vecchio, S.
Fonti, R.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S408 - S408
[27] Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase-III Trials
Fernandes, Bolivia Crocete Aloysia
Shah, Vedant
Ali, Muhammad Ashar
Shah, Abhi
Madine, Makarand
Gottumukkala, Mounika
Pandeti, Sucharitha
Syed, Safa
Nookala, Vinod
BLOOD, 2024, 144 : 6987 - 6987
[28] 18f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma
Jung, Sung-Hoon
Kwon, Seong Young
Min, Jung-Joon
Bom, Hee Seung
Ahn, Seo-Yeon
Jung, Seung-Yeon
Lee, Seung-Shin
Park, Moo-Rim
Yang, Deok-Hwan
Ahn, Jae-Sook
Kim, Hyeoung-Joon
Lee, Je-Jung
BLOOD, 2018, 132
[29] 18F-FDG PET/CT assessment of metabolic activity of the osteolytic lesions in newly diagnosed multiple myeloma patients as predictive factor for overall survival
Stoeva, T.
Dancheva, Z.
Dyankova, M.
Yordanova, T.
Chausheva, S.
Chaushev, B.
Klisarova, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S568 - S568
[30] Comparison between tumour metabolism derived from 18F-FDG PET/CT and accurate cytogenetic stratification in newly diagnosed multiple myeloma patients
Silva, Yannick
Riedinger, Jean-Marc
Chretien, Marie-Lorraine
Caillot, Denis
Corre, Jill
Guillen, Kevin
Cochet, Alexandre
Tabouret-Viaud, Claire
Loffroy, Romaric
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2021, 11 (10) : 4299 - 4309

← 1 2 3 4 5 →